Loading…
World Perfumes Inc. received a warning letter for manufacturing adulterated over-the-counter oral and topical drug products due to significant Current Good Manufacturing Practice (CGMP) violations. The company failed to conduct required identity testing on incoming components, particularly ethanol used in multiple drug products, and did not adequately test for methanol contamination—a serious concern given documented cases of lethal poisoning from methanol-contaminated ethanol worldwide. Additionally, the firm failed to verify that alcohol components met United States Pharmacopoeia (USP) monograph specifications. The FDA inspection of the facility at 2360 NW 150th Street in Opa-Locka, Florida, was conducted from May 5-9, 2025.